We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
-5.19%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$586M
AUM Growth
+$27.7M
(+5%)
Cap. Flow
+$76.8M
Cap. Flow
% of AUM
13.1%
Top 10 Holdings %
Top 10 Hldgs %
4.62%
Holding
2,170
New
811
Increased
351
Reduced
336
Closed
665
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$3.33M |
| 2 |
Eli Lilly
LLY
|
+$3.21M |
| 3 |
W.W. Grainger
GWW
|
+$2.81M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$2.81M |
| 5 |
Visa
V
|
+$2.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.68M |
| 2 |
Nasdaq
NDAQ
|
+$2.22M |
| 3 |
Oracle
ORCL
|
+$2.22M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.98M |
| 5 |
Deere & Co
DE
|
+$1.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.51% |
| 2 | Technology | 18.98% |
| 3 | Industrials | 14.56% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Financials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PR
1026
Permian Resources
PR
$16.5B
| $194K | 0.03% |
+13,900
| New | +$175K |
|
1027
Relay Therapeutics
RLAY
$3.99B
| $193K | 0.03% |
22,931
+5,216
| +29% | +$56.1K |
|
|
CDTX
1028
DELISTED
Cidara Therapeutics
CDTX
| $191K | 0.03% |
10,138
-12,319
| -55% | -$242K |
|
1029
Deluxe
DLX
$1.25B
| $191K | 0.03% |
+10,102
| New | +$196K |
|
|
TWOU
1030
DELISTED
2U Inc
TWOU
| $191K | 0.03% |
+2,575
| New | +$263K |
|
1031
James River Group Holdings
JRVR
$221M
| $189K | 0.03% |
+12,319
| New | +$201K |
|
1032
Innodata
INOD
$1.88B
| $189K | 0.03% |
22,134
+11,516
| +108% | +$129K |
|
1033
Aurinia Pharmaceuticals
AUPH
$1.92B
| $189K | 0.03% |
24,261
+10,700
| +79% | +$105K |
|
1034
P3 Health Partners
PIII
$35M
| $188K | 0.03% |
2,555
+1,220
| +91% | +$127K |
|
1035
ZIM Integrated Shipping Services
ZIM
$2.9B
| $187K | 0.03% |
17,874
+4,233
| +31% | +$53.8K |
|
1036
Sinclair Inc
SBGI
$1.02B
| $187K | 0.03% |
16,637
-6,917
| -29% | -$89.2K |
|
1037
ASE Group
ASX
$74.4B
| $186K | 0.03% |
24,751
-6,573
| -21% | -$51.1K |
|
|
OPTU
1038
Optimum Communications Inc
OPTU
$298M
| $186K | 0.03% |
56,825
+41,601
| +273% | +$134K |
|
1039
Wave Life Sciences
WVE
$1.13B
| $186K | 0.03% |
32,280
-29,181
| -47% | -$133K |
|
1040
Douglas Emmett
DEI
$2.01B
| $186K | 0.03% |
14,539
-16,707
| -53% | -$226K |
|
|
EHAB
1041
DELISTED
Enhabit
EHAB
| $185K | 0.03% |
+16,441
| New | +$207K |
|
1042
Amylyx Pharmaceuticals
AMLX
$2.17B
| $185K | 0.03% |
+10,099
| New | +$214K |
|
1043
Ribbon Communications
RBBN
$361M
| $184K | 0.03% |
68,653
-75,363
| -52% | -$220K |
|
1044
JELD-WEN Holding
JELD
$98.2M
| $184K | 0.03% |
13,767
+2,998
| +28% | +$47K |
|
|
LGF.B
1045
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $184K | 0.03% |
23,337
+8,853
| +61% | +$66.6K |
|
1046
Sotera Health
SHC
$5.06B
| $183K | 0.03% |
+12,235
| New | +$206K |
|
|
REVG
1047
DELISTED
REV Group
REVG
| $182K | 0.03% |
11,346
-10,494
| -48% | -$143K |
|
1048
Precigen
PGEN
$1.97B
| $181K | 0.03% |
127,575
-135,471
| -52% | -$192K |
|
1049
Axogen
AXGN
$2.19B
| $181K | 0.03% |
36,228
+1,268
| +4% | +$8.78K |
|
|
KLRS
1050
Kalaris Therapeutics
KLRS
$79.5M
| $181K | 0.03% |
+3,654
| New | +$249K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q3 2023 Portfolio in Review
As of Q3 2023, XTX Topco held 2,170 positions worth $586M, up 5% from $558M the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.
XTX Topco deployed $76.8M of net new capital in Q3 2023, opening 811 new positions and adding to 351 existing holdings. Its largest new stake was Idexx Laboratories: 6,687 shares worth $2.92M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Nasdaq, an estimated $2.22M trimmed.
- XTX Topco's largest Q3 2023 buy was Idexx Laboratories: 6,687 shares worth $2.92M.
- XTX Topco added most to Microsoft in Q3 2023, an estimated $2.27M increase.
- XTX Topco's biggest Q3 2023 reduction was Nasdaq, cutting an estimated $2.22M.
- XTX Topco fully exited Boeing in Q3 2023, selling an estimated $2.68M.
- XTX Topco's ten largest holdings make up 4.6% of its $586M portfolio in Q3 2023.
- XTX Topco opened 811 new positions and closed 665 in Q3 2023.
- XTX Topco's portfolio value rose 5% quarter-over-quarter to $586M.
Based on XTX Topco's 13F filing for Q3 2023, filed 13 Nov 2023.